{"product_id":"drug-repositioning-9780470878279","title":"Drug Repositioning","description":"\u003cbr\u003e\u003cb\u003eAuthor:\u003c\/b\u003e Michael J. Barratt, Donald E. Frail\u003cbr\u003e\u003cb\u003ePublisher:\u003c\/b\u003e Wiley\u003cbr\u003e\u003cb\u003ePublished:\u003c\/b\u003e 05\/29\/2012\u003cbr\u003e\u003cb\u003ePages:\u003c\/b\u003e 498\u003cbr\u003e\u003cb\u003eBinding Type:\u003c\/b\u003e Hardcover\u003cbr\u003e\u003cb\u003eWeight:\u003c\/b\u003e 1.80lbs\u003cbr\u003e\u003cb\u003eSize:\u003c\/b\u003e 9.20h x 6.10w x 1.20d\u003cbr\u003e\u003cb\u003eISBN:\u003c\/b\u003e 9780470878279\u003cbr\u003e\u003cp\u003e\u003cb\u003eAbout the Author\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eMichael Barratt\u003c\/strong\u003e is an independent consultant and previously?Senior Director and Technology Platform Leader at Pfizer's Global Indications Discovery Research Unit. He has?over 15?years of experience in preclinical drug discovery research and leadership. \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eDonald Frail\u003c\/strong\u003e is an independent consultant and previously?Vice President of Pfizer Global Research and Development and Head of Pfizer's Global Indications Discovery Research Unit. He has over 20 years of industrial research and management experience in preclinical drug discovery and early clinical research.\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003ci\u003eThis title is not returnable\u003c\/i\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Hardcover","offer_id":40008432975987,"sku":"9.78047E+12","price":146.5,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0555\/9255\/0515\/products\/img_8632ba78-d7c1-4c1d-a759-3803fb7f2dd2.jpg?v=1650386108","url":"https:\/\/bookstorenmore.com\/products\/drug-repositioning-9780470878279","provider":"Bookstore N More","version":"1.0","type":"link"}